Cerbios-Pharma bringing enhanced payload and conjugation offers to ADC World Digital virtual event

news-releasesCERBIOS-PHARMA SA
September 15th 2020

Lugano, Switzerland: – Antibody Drug Conjugate (ADC) specialist Cerbios-Pharma SA (Cerbios) will be a significant online presence as part of the PROVEO™ Alliance consortium at the upcoming ADC World Digital virtual event.

PROVEO will host a virtual booth at the online forum that will showcase its development and cGMP manufacturing service for proteins, conjugation, cytotoxic payloads and Fill Finish.

PROVEO will demonstrate the ability to provide seamless end-to-end ADC solutions for all pharma companies, bringing together complementary expertise from CERBIOS, AGC Biologics and Oncotec Pharma Produktion.

Strong PROVEO team

As leading names in the antibody drug conjugates field, PROVEO and its partners have been regular attendees at ADC World events.

PROVEO will boost a strong team for the event, including Cerbios Business Development Manager Matteo Piazza, Oncotec’s New Business Development manager, Matthias Beck, and three AGC  executives, Jason Arcediano (SVP Americas), Christoph Winterhalter (SVP Europe), and Shigeru Kunii (SVP Asia).

The team will participate to all networking events to interact with its core audience of pharma companies, start-ups and technological innovators looking for service quality, on-time delivery, seamless supply chain integration and effective manufacturing technologies.

About Cerbios-Pharma

Cerbios is a privately held company located in Lugano, Switzerland, that specializes in the development and manufacturing of both chemical and biological APIs for its partners world-wide.

Exclusive CDMO services are offered for the development and manufacturing of high potency active ingredients (HPAIs) as well as for biological products including monoclonal antibodies, recombinant proteins and antibody drug conjugates (ADCs).

Cerbios provides full CMC support, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs, with paramount ability to support a successful registration. Cerbios is a worldwide presence with partners in Europe, USA and Japan.

Cerbios division, PROVEO, in partnership with AGC Biologics and Oncotec, focus on integrated ADC manufacturing solutions.

PROVEO can offer a ADCs end-to-end service from drug substance development till sterile fill & finish.

About World ADC Digital 2020

The World ADC Conference is the industry’s longest standing and most comprehensive event devoted to Antibody Drug Conjugate technology and solutions, dedicated to sharing new insights and connections to promote development of more clinically impactful ADCs.

Due to the COVID-19 pandemic, the 11th conference, originally scheduled to open on October 11 in San Diego, has been supplemented by World ADC Digital, a digital event that will also run for four days from September 15.

This virtual conference will also cover every element of ADC drug development forming an end-to-end learning experience and enabling personal online interactions within the ADC community.

The online experience will include more than 75 industry expert speakers, over five themed tracks, focused seminar days and 10 interactive workshops, including cutting-edge content leading industry providers.

The event is organized by Hanson Wade with more information at: World ADC Digital 2020


Click on Cerbios-Pharma ADC Services for detailed information.


CERBIOS-PHARMA Company Brochure

Cerbios-Pharma bringing enhanced payload and conjugation offers to ADC World Digital virtual event

Cerbios-Pharma at ADC World Digital